II. International Europa-Park Symposium on Cardiac Arrhythmias

Transkript

1 II. International Europa-Park Symposium on Cardiac Arrhythmias Saturday, June 28th, 2014 Hotel Colosseo, Europa-Park Rust, Germany Final Program Chairman Prof. Juraj Melichercik, MD, PhD MediClin Heart Center Lahr / Baden, Germany

2 Redefining Ablation Technology All cited trademarks are the property of their respective owners. CAUTION: The law restricts these devices to sales by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Information for the use only in countries with applicable health authority product registrations. EP AA_NOV Boston Scientific Corporation or its affiliates. All rights reserved.

3 II. International Europa-Park Symposium on Cardiac Arrhythmias Welcome Address Dear Colleagues and Friends, It is my great pleasure to invite you to attend the 2nd International Europa-Park Symposium on Cardiac Arrhythmias which will be held on the 28th of June, 2014, in Rust, Germany. The Symposium was initiated in 2012 in response to the remarkable progress that has been made in the management of cardiac arrhythmias, over the past number of years. The second edition of this symposium will focus on many important areas of cardiac arrhythmias: atrial fibrillation, ventricular arrhythmias, inherited rhythm disorders, device therapy, cardiac resynchronisation therapy and new percutaneous treatment modalities that could facilitate the therapy of cardiac arrhythmias. An outstanding Faculty, consisting of distinguished cardiologists and speakers, will provide attendees with comprehensive and practical lectures in a collegial atmosphere. The Symposium will be held at the Hotel Colosseo in Rust, which is set in a delightful and culturally rich region, near the borders of Germany, France and Switzerland. Looking forward to seeing you in Rust! Sincerely, Prof. Juraj Melichercik, MD, PhD chairman

4 Scientific & Organizing Committee Prof. Dr. J. Melichercik, Lahr / DE Prof. E. von Hodenberg, Lahr / DE Faculty Prof. Dr. S. Bauer, Lahr / DE Prof. Dr. Ch. Bea, Freudenstadt / DE Prof. Dr. J. Brachmann, Coburg / DE Prof. Dr. G. Breithardt, Münster / DE Prof. Dr. Josep Brugada, Barcelona / ES Prof. Dr. J. Ennker, Lahr / DE Dr. S. Ernst, London / UK Dr. J. Härtig, Lahr / DE Prof. Dr. R. Hatala, Bratislava / SK Prof. Dr. B. Ismer, Offenburg / DE Prof. W. Jung, Villingen-Schwenningen / DE Prof. Dr. K-H. Kuck, Hamburg / DE Prof. Dr. T. Lewalter, Munich / DE Prof. Dr. J. Melichercik, Lahr / DE Prof. Dr.-Ing. P. Osypka, Rheinfelden / DE Prof. Dr. E. Pokushalov, Novosibirsk / RU Dr. U. Rosendahl, London / UK Prof. Dr. W. Schöls, Duisburg / DE Prof. Dr. C. Schmitt, Karlsruhe / DE Prof. Dr. O. Strohm, Baden-Baden / DE Prof. Dr. E. Vester, Düsseldorf / DE Prof. Dr. E. Von Hodenberg, Lahr / DE Prof. Dr. M. Zehender, Freiburg / DE

5 P r o g r a m Official Language Sitzung I + II: Deutsch Session I + II: German Session III + IV: English 9:00 9:05 9:05 10:25 9:05 9:25 9:25 9:45 Eröffnung Opening Sitzung I: Schlaganfall Prävention bei Vorhofflimmern Session I: Stroke Prevention in Atrial Fibrillation Neue orale Antikoagulantien: Indikation und Datenlage New Oral Anticoagulations: Indication and Evidence Ist die Behandlung mit Warfarin / Phenprocoumon obsolet? Is Therapy with Warfarin / Phenprocoumon obsolete? J. Melichercik, Lahr Vorsitz: Chairmen: J. Brachmann, Coburg F. Bea, Freudenstadt W. Schöls, Duisburg W. Jung, Villingen- Schwenningen 9:45 10:05 Bedeutung der Katheterablation für die Schlaganfall-Prävention Role of Catheter Ablation for Stroke Prevention E. Vester, Düsseldorf 10:05 10:25 Wann könnte der Vorhofohrverschluss die bessere Therapieoption zur Schlaganfall-Prävention sein? When LAA Closure Might Be a Better Therapeutic Option for Stroke Prevention? J. Melichercik, Lahr

6 10:25 11:00 11:00 11:30 11:30 13:10 11:30 11:50 11:50 12:10 12:10 12:30 Ehrenvortrag: 50 Jahre Biomedizintechnik Honorary Lecture: 50 Years Biomedical Engineering Laudatio Kaffee-Pause Coffee break Sitzung II: Device-Therapie Session II: Device Therapy Fortschritte in der Schrittmacherund Defibrillatortherapie Advances in Pacemaker and ICD Therapy Sonden-Management / Extraktion in der klinischen Praxis Lead Management (Extraction) in Clinical Practice Gerätebasierte Telemetrie zur Früherkennung von klinischen und technischen Problemen Device-Based Remote Monitoring for Early Detection of Clinical and Technical Problems P. Osypka, Rheinfelden G. Breithardt, Münster Vorsitz: Chairmen: J. Ennker, Lahr O. Strohm, Baden-Baden J. Brachmann, Coburg S. Bauer, Lahr J. Härtig, Lahr

7 P r o g r a m 12:30 12:50 12:50 13:10 13:10 14:00 14:00 14:30 14:30 15:30 14:30 14:50 14:50 15:10 Kathetergestützter Aortenklappenklappenersatz ( TAVI ) und Herzrhythmusstörungen Transcatheter Aortic Valve Implantation and Cardiac Arrhythmias Nicht invasive Strategien zur Vorhersage eines Ansprechens einer CRT Therapie Non-Invasive Strategies to Predict CRT Response Mittagessen Lunch Keynote Lecture: Ablation of Atrial Fibrillation: Lessons from the Past and Future Challenges Session III: Ablation Therapy New Technologies for AF Ablation: Do They Really Add Value to our Practice? Mapping and Ablation of Focal Atrial Tachycardia E. von Hodenberg, Lahr B. Ismer, Offenburg K-H. Kuck, Hamburg Vorsitz: Chairmen: C. Schmitt, Karlsruhe G. Breithardt, Münster T. Lewalter, Munich C. Schmitt, Karlsruhe

8 15:10 15:30 15:30 16:00 16:00 17:30 16:00 16:20 16:20 16:40 16:40 17:00 17:00 17:20 17:20 18:00 18:00 Advances in Catheter Ablation of Ventricular Arrhythmias Coffee break Kaffeepause Session IV: Varia Cardio-Genetics of Arrhythmias Autonomic Nervous System and Cardiac Arrhythmias Challenges and controversies in CRT Percutaneous Mitral Valve Repair in Patients with CRT Closing Remarks Snack Imbiss S. Ernst, London Vorsitz: Chairmen: U. Rosendahl, London E. von Hodenberg, Lahr J. Brugada, Barcelona E. Pokushalov, Novosibirsk R. Hatala, Bratislava M. Zehender, Freiburg E. von Hodenberg, Lahr

9 Regular Industry Student, Nurse * Registration fee 60,00 eur 60,00 eur 30,00 eur * proof of employment is mandatory ** incl. Snack Payment Information Payment by Credit Card only. (Visa, Mastercard, American Express) Registration online: Accreditation The symposium will be accredited by LÄK Baden Württemberg / Germany with presumably 8 points.

10 Patron Deutsche Gesellschaft für Kardiologie Herz- und Kreislaufforschung e. V. Platin Sponsor Gold Sponsors 6.000,- euro * Silber Sponsors 3.000,- euro * 2.500,- euro * 2.500,- euro * Bronze Sponsors je 1.000,- euro * 500,- euro * * Offenlegung der Unterstützung gemäß erweiterter Transparenzvorgabe des FSA-Kodex Fachkreise ( 20 Abs. 5) Financial support used for advertising and exhibition space We thank all the sp onsors for realizing the Symp osium!

11 Das kleinste EKG der Welt.

12 II. International Europa-Park Symposium on Cardiac Arrhythmias Symposium Information Venue: Hotel Colosseo Europa-Park Rust Germany Date: 28th, 2014 Scientific Secretariat Prof. Juraj Melichercik, MD, PhD Department of Internal Medicine, Cardiology and Angiology MediClin Heart Center Lahr / Baden Hohbergweg Lahr Germany juraj.melichercik@mediclin.de Organizing Secretariat KORESE Convention & Event Service GmbH Kornhausgasse Ravensburg Germany iepsca@korese.com